The MPP organizes a training course on clinical evaluation under the MDR on 26 May 2021

Basel, 10 May 2021

The Medtech & Pharma Platform Association (MPP) next virtual training course on an ‘Introduction to clinical evaluation under the MDR’ will take place online on 26 May 2021, 1:00-3:45 pm CEST.


The course will be moderated by Shayesteh Fürst-Ladani (SFL CEO and MPP President) and led by experts in field of medical devices Marta Swierczynska (Senior Manager Regulatory Affairs, SFL), Patricia McHugh Giordano (Executive Director, Medical Safety Lead for Devices and Product Quality, MSD), Joshua Samuels (Director of Clinical Evaluations, Johnson & Johnson), Alice Genevet (Senior Manager Medical Affairs & Regulatory Affairs, SFL) and Ulrich Nitsche (Clinical Reviewer, TÜV-SÜD).


The training course will provide a comprehensive overview of the requirements and challenges for clinical evaluation of medical devices under the MDR. It will present complementary perspectives and experiences from the industry and Notified Body experts.

More information can be obtained here.